At current prices Novo Nordisk is a Strong Buy. It's good positioning in the promising weight loss segment, solid foundation ...

Early trials of the drug, retatrutide, have already shown it can help people shed a quarter of their body weight in under a ...

The technology sector makes up just over a third of the S&P 500 with a 34% weighting. The tech sector includes the three ...

The drug, which is estimated to be taken by up to 750,000 people, is one of the country's most popular weight loss and ...

A powerful new medication is being hailed as the 'Godzilla' of weight-loss shots. It has been suggested retatrutide can help people shed a quarter of their body weight in under a year - almost twice ...

Vivienne Joy runs a community of hundreds of weight loss jab users and said the increased cost of Mounjaro had 'created chaos' ...

Robert F. Kennedy Jr.’s leadership at HHS sparks controversy as his vaccine agenda reshapes policy, regulation, and public health.

Viking Therapeutics (NASDAQ:VKTX), often touted as an attractive obesity play, shed more than a third of its value this week ...

Included in several documents are confirmation that investigators found a second piece of a pink blanket they say belonged to ...

The court filings show at least four polygraph examinations were conducted by investigators and that initial polygraphs for ...